Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Collegium PharmaceuticalFRA:354 -1.95%76 Days Inventory is 49.73 as of Mar. 2026, which is 6% above its 10-year median of 46.77. GuruFocus rates FRA:354 with a GF Score™ of 76/100 and a GF Value™ of €37.50 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Collegium Pharmaceutical ranks better than 95.34% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Collegium Pharmaceutical's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Collegium Pharmaceutical's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.21.
Collegium Pharmaceutical (FRA:354) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Collegium Pharmaceutical's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Collegium Pharmaceutical's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Collegium Pharmaceutical Days Inventory Related Terms
Collegium Pharmaceutical Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:354 vs ALVO, PAHC, BIOA: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Collegium Pharmaceutical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Collegium Pharmaceutical Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Collegium Pharmaceutical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Collegium Pharmaceutical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Collegium Pharmaceutical (FRA:354) has a Days Inventory of 49.73 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Collegium Pharmaceutical and its competitors. This is near median its historical median of 46.77. Over the past decade, Collegium Pharmaceutical's Days Inventory has ranged from 10.61 to 2,255.12. According to the industry distribution chart, Collegium Pharmaceutical ranks #43 out of 923 companies in the Drug Manufacturers industry, placing it in the top 4.7%.
Is Collegium Pharmaceutical's Days Inventory too high?
Collegium Pharmaceutical's current Days Inventory of 49.73 is near median its 10-year median of 46.77. Over the past 10 years, this metric has ranged from a low of 10.61 to a high of 2,255.12. The Drug Manufacturers industry median Days Inventory is 164.48. Collegium Pharmaceutical's value of 49.73 is 69.8% below this industry median. Based on the distribution chart, Collegium Pharmaceutical ranks #43 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Collegium Pharmaceutical has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Collegium Pharmaceutical's Days Inventory compare to ALVO and PAHC?
According to the Drug Manufacturers industry distribution chart, Collegium Pharmaceutical ranks #43 out of 923 companies for Days Inventory. This places Collegium Pharmaceutical in the top 5% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Collegium Pharmaceutical's value of 49.73 is 69.8% below this benchmark. Historically, Collegium Pharmaceutical's own Days Inventory has ranged from 10.61 to 2,255.12 over the past decade. While the company's 10-year median is 46.77 vs. the industry median of 164.48, Collegium Pharmaceutical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Collegium Pharmaceutical's current Days Inventory of 49.73 is 69.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Collegium Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Collegium Pharmaceutical's current Days Inventory is 49.73, which is near median its own 10-year median of 46.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Collegium Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Collegium Pharmaceutical (FRA:354) is currently considered Modestly Undervalued. The stock's GF Value™ is €37.50, compared to a current price of €30.20 — trading 19.5% below its estimated fair value. The current Days Inventory is 49.73, which is near median its 10-year median of 46.77 and 69.8% below the Drug Manufacturers industry median of 164.48. Collegium Pharmaceutical's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Collegium Pharmaceutical (FRA:354), the current Days Inventory is 49.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Collegium Pharmaceutical (FRA:354) Overvalued in 2026?
Based on GuruFocus' analysis, Collegium Pharmaceutical stock appears to be undervalued.
The current stock price of €30.20 is trading 19.5% below its estimated GF Value™ of €37.50.
GuruFocus considers Collegium Pharmaceutical to be Modestly Undervalued.
Key valuation signals for FRA:354:
Days Inventory: 49.73 (near median its 10-year median of 46.77)
GF Value™: €37.50 vs. price of €30.20 (19.5% below fair value)
Industry Position: 69.8% below the Drug Manufacturers median (#43 of 923)
No single metric tells the full story. See the FRA:354 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
76GF Score
Get the complete analysis for FRA:354
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:354 has been successfully added to your 
